alexa
Reach Us +1-217-403-9671
Holistic Pharma For All | 7401
ISSN: 2167-7689

Pharmaceutical Regulatory Affairs: Open Access
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Holistic pharma for all

2nd International Conference and Exhibition on Pharmaceutical Regulatory Affairs

S. V. Eswaran

ScientificTracks Abstracts: Pharmaceut Reg Affairs

DOI: 10.4172/2167-7689.S1.002

Abstract
Pharmaceuticals have undoubtedly contributed to increased life expectancy and better quality of life, especially in old age. Lifestyle based diseases are now better managed but factors leading to ageing and neurodegenerative diseases are yet to be understood fully. In addition to ?curing? diseases, one has to engage in locating the origin of diseases. A more holistic approach combining different systems of medicine is called for. This helps reduce overdependence and also makes treatment more affordable. In the forthcoming era of personalized medicine, low dose formulations will play a more important role. The question of affordability also has to be constantly kept in mind. Can a vitamin, for example, be prohibitively costly? Many Indian scientific organizations and companies have made great inroads in this regard. The success stories of IICT, Hyderabad, AVRO Labs.- CIPLA, Ranbaxy, ORCHID, Glenmark are noteworthy. The CSIR-OSDD initiative in combating tropical diseases and invoking telemedicine are indeed laudable.
Biography
S. V. Eswaran has taught for 43 years. Served as Principal, Deshbandhu College, Delhi, 2001-2003 and as a member of national committees, e. g. Star Colleges Committee, Department of Biotechnology, Government of India, Shiv Nadar University, Greater NOIDA; Ph. D., Delhi, 1973; Post- Doc. Max Planck Institute for Biochemistry, Munich, 1976-77; Universities of Heidelberg; Karlsruhe, 1984; Goettingen, 1997; Technical University, Delft,1990; Ohio State University, Columbus, 1997; Brown University, 2006; CRSI Best teacher award, 2007; University of Delhi distinguished teacher award, 2009; DAAD-UGC fellowship, 1976-77. Published 60 papers, patents and supervised 4 Ph. D. and 21 M. Sc/ M. Tech. thesis.
Top